Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Oxymycine La 300 300 mg Solution is a Health Canada–registered veterinary drug (DIN 02274892) held by Zoetis Canada Inc, containing Oxytetracycline (Oxytetracycline Dihydrate). Health Canada lists its status as Cancelled Post Market (status date 01 Jun 2026).

Health Canada registration

DIN02274892
Brand nameOxymycine La 300
Active ingredientOxytetracycline (Oxytetracycline Dihydrate)
Strength300 mg
Dosage formSolution
RouteIntramuscular ; Subcutaneous
CompanyZoetis Canada Inc
StatusCancelled Post Market — 01 Jun 2026
ClassVeterinary
ATC
AHFS
Regulator recordHealth Canada DPD entry · Product monograph

Status and company history

Changes Health Canada has recorded for this DIN, as observed by Nexara Health's weekly DPD comparison.

DateFieldFromTo
2026-09-03StatusDormantCancelled Post Market
2026-09-03StatusDormantCancelled Post Market

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Oxymycine La 300 (DIN 02274892) marketed in Canada?

No. Health Canada lists DIN 02274892 as Cancelled Post Market as of 01 Jun 2026.

Who holds the Canadian licence for this product?

Zoetis Canada Inc is the company of record in the Health Canada Drug Product Database.

Is the same medicine registered outside Canada?

No same-molecule registration has been matched in the 56 national registries Nexara Health tracks. Contact us to check manually.

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02274892, status date 2026-06-01. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02274892, status date 2026-06-01.

Health Canada Drug Product Database (DPD), DIN 02274892, status date 2026-06-01. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.